Search Result "DDI Risk Assessment"
Drug-Drug Interactions via Mechanism-Based Cytochrome P450 Inactivation: Points to Consider for Risk Assessment from In Vitro Data and Clinical Pharmacologic Evaluation
Journal: Current Drug Metabolism
Volume: 8 Issue: 5 Year: 2007 Page: 449-462
Author(s): Karthik Venkatakrishnan, R. Scott Obach
Prediction of Drug-Drug Interactions Arising From Mechanism-Based Inactivation: Key Input Parameters and Impact on Risk Assessment
Journal: Current Drug Metabolism
Volume: 12 Issue: 9 Year: 2011 Page: 871-890
Author(s): Simon G. Wong
Assessment of Cytochrome P450 Enzyme Inhibition and Inactivation in Drug Discovery and Development
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 382-403
Author(s): David O. Nettleton, Heidi J. Einolf
Comprehensive Assessment of ADMET Risks in Drug Discovery
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 2195-2219
Author(s): Jianling Wang
Assessment of Possible Drug Interactions in Patients with Psoriasis and Associated Comorbid Medical Conditions: An Observational Study
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 128-134
Author(s): Reena Sherin, Padmaja Udaykumar
2020 FDA Drug-drug Interaction Guidance: A Comparison Analysis and Action Plan by Pharmaceutical Industrial Scientists
Journal: Current Drug Metabolism
Volume: 21 Issue: 6 Year: 2020 Page: 403-426
Author(s): Sirimas Sudsakorn,Praveen Bahadduri,Jennifer Fretland,Chuang Lu
A Prospective Analysis of Potential and Observed Drug-Drug Interactions, Adverse Events and its Associated Risk Factors in Hospitalized Cardiology Patients in Benin
Journal: Current Drug Safety
Volume: 15 Issue: 3 Year: 2020 Page: 190-197
Author(s): Aurel C.E. Allabi,Yessoufou Tchabi,Murielle Hounkponou,Rebecca Quenum,Jeanne Vehounkpe-Sacca
Clinical Risk Management of Interactions Between Natural Products and Drugs
Journal: Current Drug Metabolism
Volume: 9 Issue: 1 Year: 2008 Page: 1055-1062
Author(s): Peter A.G.M. De Smet, Annemieke Floor-Schreudering, Marcel L. Bouvy, Michel Wensing
A Transcellular Assay to Assess the P-gp Inhibition in Early Stage of Drug Development
Journal: Drug Metabolism Letters
Volume: 6 Issue: 4 Year: 2012 Page: 285-291
Author(s): Jan-Shiang Taur, Edgar L. Schuck, Nancy Y. Wong
Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1
Journal: Current Drug Metabolism
Volume: 25 Issue: 3 Year: 2024 Page: 197-204
Author(s):